SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
Pharmacology
[키워드] ACE2 receptor
acting
administration
angiotensin-converting enzyme 2 receptors
Antibiotics
Antimalarial drugs
Antiretrovirals
antiviral activity
approach
certainty
Clinical features
convalescent plasma
coronavirus
coronavirus disease
corticoids
COVID-19
current therapy
drug
effective
Endocytic pathway
endocytosis
Epitopes
host-virus interaction
Hydroxychloroquine
identify
immune
immune response
immune system disorders
immunosuppressive drug
Inflammatory cytokines
initial
interferons
kinase inhibitors
Mesenchymal stem cells
monoclonal antibodies
monoclonal antibody
neutralization
nucleotide analogue
Numerous
pandemic
pathogenic mechanism
pathogenic mechanisms
promote
Remdesivir
RNA-dependent RNA polymerase
Safe
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike protein
SARS-CoV-2 vaccine
Side effect
similarity
Spread
stem cells
Still
therapeutic option
therapeutic targets
therapy
Treatment
Trial
triggered
Vaccine
virus
[DOI] 10.3389/fphar.2020.01224 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.01224 PMC 바로가기 [Article Type] Pharmacology